BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30957677)

  • 21. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
    Canzian F; Amati P; Harach HR; Kraimps JL; Lesueur F; Barbier J; Levillain P; Romeo G; Bonneau D
    Am J Hum Genet; 1998 Dec; 63(6):1743-8. PubMed ID: 9837827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer.
    Diquigiovanni C; Bergamini C; Evangelisti C; Isidori F; Vettori A; Tiso N; Argenton F; Costanzini A; Iommarini L; Anbunathan H; Pagotto U; Repaci A; Babbi G; Casadio R; Lenaz G; Rhoden KJ; Porcelli AM; Fato R; Bowcock A; Seri M; Romeo G; Bonora E
    Int J Cancer; 2018 Oct; 143(7):1706-1719. PubMed ID: 29672841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aryl hydrocarbon receptor interacting protein mutations seem not to associate with familial non-medullary thyroid cancer.
    Raitila A; Georgitsi M; Bonora E; Vargiolu M; Tuppurainen K; Mäkinen MJ; Vierimaa O; Salmela PI; Launonen V; Vahteristo P; Aaltonen LA; Romeo G; Karhu A
    J Endocrinol Invest; 2009 May; 32(5):426-9. PubMed ID: 19794292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial Aggregation and Heritability of Nonmedullary Thyroid Cancer in an Asian Population: A Nationwide Cohort Study.
    Lin HT; Liu FC; Lin SF; Kuo CF; Chen YY; Yu HP
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32333767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.
    Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY
    Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Germline
    Zhao Y; Yu T; Chen L; Xie D; Wang F; Fu L; Cheng C; Li Y; Zhu X; Miao G
    Thyroid; 2020 Jun; 30(6):924-930. PubMed ID: 32041497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing.
    Srivastava A; Giangiobbe S; Kumar A; Paramasivam N; Dymerska D; Behnisch W; Witzens-Harig M; Lubinski J; Hemminki K; Försti A; Bandapalli OR
    Front Bioeng Biotechnol; 2020; 8():179. PubMed ID: 32211398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.
    Yu Y; Dong L; Li D; Chuai S; Wu Z; Zheng X; Cheng Y; Han L; Yu J; Gao M
    Sci Rep; 2015 Nov; 5():16129. PubMed ID: 26530882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance.
    He H; Li W; Wu D; Nagy R; Liyanarachchi S; Akagi K; Jendrzejewski J; Jiao H; Hoag K; Wen B; Srinivas M; Waidyaratne G; Wang R; Wojcicka A; Lattimer IR; Stachlewska E; Czetwertynska M; Dlugosinska J; Gierlikowski W; Ploski R; Krawczyk M; Jazdzewski K; Kere J; Symer DE; Jin V; Wang Q; de la Chapelle A
    PLoS One; 2013; 8(5):e61920. PubMed ID: 23690926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.
    Cirello V; Colombo C; Karapanou O; Pogliaghi G; Persani L; Fugazzola L
    Front Endocrinol (Lausanne); 2020; 11():589340. PubMed ID: 33488516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).
    Pereira JS; da Silva JG; Tomaz RA; Pinto AE; Bugalho MJ; Leite V; Cavaco BM
    Endocrine; 2015 May; 49(1):204-14. PubMed ID: 25381600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variants in microRNA genes in familial papillary thyroid carcinoma.
    Tomsic J; Fultz R; Liyanarachchi S; Genutis LK; Wang Y; Li W; Volinia S; Jazdzewski K; He H; Wakely PE; Senter L; de la Chapelle A
    Oncotarget; 2017 Jan; 8(4):6475-6482. PubMed ID: 28031538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multigenerational familial medullary thyroid cancer (FMTC): evidence for FMTC phenocopies and association with papillary thyroid cancer.
    Fugazzola L; Cerutti N; Mannavola D; Ghilardi G; Alberti L; Romoli R; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):53-63. PubMed ID: 11849247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic susceptibility to hereditary non-medullary thyroid cancer.
    Kamani T; Charkhchi P; Zahedi A; Akbari MR
    Hered Cancer Clin Pract; 2022 Mar; 20(1):9. PubMed ID: 35255942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline Mutations in Familial Papillary Thyroid Cancer.
    Sarquis M; Moraes DC; Bastos-Rodrigues L; Azevedo PG; Ramos AV; Reis FV; Dande PV; Paim I; Friedman E; De Marco L
    Endocr Pathol; 2020 Mar; 31(1):14-20. PubMed ID: 32034658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium.
    Lesueur F; Stark M; Tocco T; Ayadi H; Delisle MJ; Goldgar DE; Schlumberger M; Romeo G; Canzian F
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2157-62. PubMed ID: 10372725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically-relevant Germline Variants in Children with Non-Medullary Thyroid Cancer.
    van der Tuin K; Ruano D; Knijnenburg J; van der Luijt RB; Morreau H; Links TP; Hes FJ;
    J Clin Endocrinol Metab; 2024 Feb; ():. PubMed ID: 38415346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline compound heterozygous poly-glutamine deletion in USF3 may be involved in predisposition to heritable and sporadic epithelial thyroid carcinoma.
    Ni Y; Seballos S; Fletcher B; Romigh T; Yehia L; Mester J; Senter L; Niazi F; Saji M; Ringel MD; LaFramboise T; Eng C
    Hum Mol Genet; 2017 Jan; 26(2):243-257. PubMed ID: 28011713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.
    Pinheiro M; Drigo SA; Tonhosolo R; Andrade SCS; Marchi FA; Jurisica I; Kowalski LP; Achatz MI; Rogatto SR
    Oncotarget; 2017 Jun; 8(25):40896-40905. PubMed ID: 28402931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family.
    Kumar A; Bandapalli OR; Paramasivam N; Giangiobbe S; Diquigiovanni C; Bonora E; Eils R; Schlesner M; Hemminki K; Försti A
    Sci Rep; 2018 Aug; 8(1):11635. PubMed ID: 30072699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.